Immunoassay Market Outlook Highlighting Key Drivers And Market Evolution

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Immunoassay Market In 2026 And 2030?

The immunoassay market has experienced robust expansion in recent years. Projections indicate it will expand from $37.32 billion in 2025 to reach $40.07 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this growth has been driven by factors such as the increasing prevalence of infectious and chronic diseases, higher clinical laboratory testing volumes, the broad acceptance of elisa-based diagnostics, a surge in pharmaceutical research activities, and the escalating need for early disease detection.

The immunoassay market size is projected to experience substantial expansion in the coming years, with an anticipated increase to $52.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period is primarily driven by several factors, including the escalating demand for rapid diagnostic solutions, greater investments in personalized medicine, the broadening of decentralized testing approaches, the expanding integration of digital laboratory workflows, and a heightened emphasis on companion diagnostics. Key trends expected over the forecast horizon encompass the increasing uptake of high-sensitivity immunoassay kits, the greater utilization of automated immunoassay analyzers, the rising need for point-of-care immunoassay testing, the development of multiplex immunoassay platforms, and improved integration of data management software.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Key Factors Are Driving The Immunoassay Market Growth?

A growing prevalence of infectious and chronic diseases is projected to drive the expansion of the immunoassay market. These conditions are defined as ailments originating from pathogens or persistent health issues demanding continuous oversight, diagnosis, and care. Their increase is linked to heightened exposure to environmental pollutants, which compromises immune systems and raises vulnerability to diseases. Consequently, the immunoassay market is experiencing higher demand, as the swift spread of these illnesses compels businesses to utilize sophisticated diagnostic methods for prompt detection, disease tracking, and precise clinical judgments. For illustration, data from June 2025 by the UK Health Security Agency (UKHSA), a public health entity in the United Kingdom, indicated that reported Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024. This signifies an increase of 10,297 cases (17.1%) and an elevated reporting rate from 104.1 to 121.9 per 100,000 population. Thus, the growing incidence of infectious and chronic diseases is fueling the demand within the immunoassay market.

What Are The Different Segment Types In The Immunoassay Market Segment Breakdown?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Trends Are Guiding The Direction Of The Immunoassay Market?

Major companies in the immunoassay market are launching innovative immunoassay analyzers to gain a competitive advantage. These laboratory instruments are designed to automate and facilitate the detection and quantification of biological molecules, such as proteins or hormones, through immunological reactions. For instance, in May 2023, Beckman Coulter Diagnostics, a US-based company focused on simplifying, automating, and innovating complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses the demands of clinical laboratories regarding speed, reliability, reproducibility, quality, and menu expansion. It has demonstrated the capability to develop increasingly sensitive and clinically relevant assays, thereby amplifying the impact of new pharmaceutical therapies and ultimately improving patient outcomes. Its innovations include new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, making it the only immunoassay analyzer system that requires no daily maintenance.

Who Are The Well-Known Companies In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Get The Full Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Region Is The Largest In The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Immunoassay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795